Less than 20% of those diagnosed with a brain tumour survive beyond five years
“He could have been our first black Prime Minister but, at 21, he was cut down by a brain tumour” MPs hear of tragic burden of the disease
A bereaved woman whose son died at the age of 21 from a highly aggressive brain tumour was among other relatives and patients at Westminster today as MPs were told of the “unbearable” burden of the disease.
Alexander Paul died 17 months ago, a little more than a year after he was diagnosed with a highly aggressive glioblastoma multiforme (GBM) brain tumour. Intelligent and charismatic, Alexander undoubtedly had the brightest of futures ahead of him and, after addressing the Conservative Party Conference on national policing policy, was even touted as a potential future prime minister.
His mum Joanna Brown, from Crystal Palace, said: “Alexander was at college in Clapham when he took part in a focus group on police stop and search policy. From there he was invited to feedback directly to the then Home Secretary Theresa May and that was followed by a dramatic invitation for him to address the 2014 Conservative Party Conference.
“I almost burst with pride watching my son address the leaders of our country, an 18-year-old black boy who had yet to vote was contributing to a review of national policing policy. Some of his friends half joked he could have been the first black Prime Minister and, after that, Alexander’s talk was of being a lawyer, a journalist, or a politician.”
But three years after his speech, Prime Minister Mrs May used the same conference platform to announce the young man’s death. In the intervening period he had been given the terminal diagnosis, underwent surgery, tailored his diet, and underwent six weeks of radiotherapy followed by chemotherapy. Alexander also travelled to Germany for treatment, which was paid for partly with money borrowed from friends and through crowdfunding.
His devastated mum, a lawyer, was attending the All-Party Parliamentary Group (APPG-BT) on brain tumours as it held it launched the group’s new report Brain tumours – a cost too much to bear? published today.
The report on the economic and social impact of brain tumours is the result of a Parliamentary inquiry which received more than 200 online submissions from patients and their families and comprehensive written submissions from charities and academics. It also held oral evidence sessions during June and July from researchers, doctors, surgeons, academics, representatives of drug companies as well as brain tumour patients of all ages and their families.
Ms Brown’s poignant words feature in the report: “Alexander had the world at his feet but our nightmare was about to begin. It is this sense of crushing loss, this waste of potential that haunts my days. He did so much but could have done so much more. When Alexander was diagnosed with a glioblastoma in March 2016, I did everything I could but I couldn’t save my son and he died in June 2017.
“Our tragedy is a wider tragedy also, as society needs men like my son, Alexander.”
The key findings of the report include:
- The incapacitating nature of a brain tumour, a cancer of the body’s most important organ, can see patients faced with an immediate financial burden and the severity of the disease all too often means people contribute less to the economy and society at large.
- Costs range from loss of income through to higher domestic bills and costly home modifications. Additionally, and as in Stephen’s case, patients are required to surrender their driving licence, leading to a loss of independence.
- The experience of children, teenager and young adult patients is dismaying; they will experience more ‘social’ issues as the disease affects them at an important stage of their development and they have to bear its burden for the rest of their lives.
Derek Thomas MP for St Ives and Chair of the APPG said: “It was impossible not to have been personally affected by the wealth of emotionally compelling personal stories we heard during the course of this Inquiry and my most heartfelt thanks go to all of the brain tumour patients and their families who helped us with this report. For those of us who were privileged to hear this evidence first hand it was an experience that will stay with us for a very long time. Over the coming months and years, we will use the results of this Inquiry to keep brain tumours on the political agenda and improve outcomes for brain tumour patients.”
Sue Farrington Smith MBE, Chief Executive of the Brain Tumour Research charity, said: “We are extremely grateful to Joanna for her courage in sharing her very personal story which demonstrates why we must continue to highlight this issue and do everything we can to improve outcomes for brain tumour patients.
“Understanding the very high ongoing costs of brain tumours is vital and the Government must find additional ways to minimise these costs. We will continue to influence and find ways to minimise this unique burden through a combination of further research funding, earlier diagnosis, additional benefits, and improved post-treatment support for brain tumour patients and their families.”
For further information, please contact:
Farel James at Brain Tumour Research on 07592 502708 or Farel.James@braintumourresearch.org
Notes to Editors
Brain Tumour Research is the only national charity in the UK dedicated to raising funds for continuous and sustainable scientific research into brain tumours, and we are a leading voice calling for greater support and action for research into what scientists are calling the last battleground against cancer.
We are building a network of experts in sustainable research at dedicated Centres of Excellence whilst influencing the Government and larger cancer charities to invest more nationally.
We welcome recent funding announcements for research into brain tumours from the UK Government and Cancer Research UK – £65 million pledged over the next five years. However, this potential funding of £13 million a year comes with a catch – money will only be granted to quality research proposals and, due to the historic lack of investment, there may not be enough of these applications that qualify for grants from this pot.
We want research funding parity with breast cancer and leukaemia. We are calling for a £30-35 million investment every year for research into brain tumours in order to fund the basic research groundwork needed to accelerate the translation from laboratory discoveries into clinical trials and fast-track new therapies for this devastating disease.
The Brain Tumour Research charity is a powerful campaigning organisation and represents the voice of the brain tumour community across the UK. We helped establish and provide the ongoing Secretariat for the All Party Parliamentary Group for Brain Tumours (APPGBT). We are supporting the crucial APPGBT 2018 Inquiry into the economic and social impacts of brain tumours and will publish their report in the autumn. We are also a key influencer in the development strategy for the Tessa Jowell Brain Cancer Mission.
Key statistics on brain tumours:
- Brain tumours are indiscriminate; they can affect anyone at any age
- Brain tumours kill more children and adults under the age of 40 than any other cancer
- Historically, just 1% of the national spend on cancer research has been allocated to brain tumours
- In the UK, 16,000 people each year are diagnosed with a brain tumour
- Brain tumours kill more children than leukaemia
- Brain tumours kill more men under 45 than prostate cancer
- Brain tumours kill more women under 35 than breast cancer
- Less than 20% of those diagnosed with a brain tumour survive beyond five years compared with an average of 50% across all cancers
Please quote Brain Tumour Research as the source when using this information. Additional facts and statistics are available from our website. We can also provide case studies and research expertise for the media.